Innovation pipelines
Our institute has a wide range of technologies, capabilities and services available to industry.
To discuss partnering opportunities, please get in touch with our Business Managers: glycomicsbusinessteam@griffith.edu.au
Vaccines
Antigen discovery | Vaccine prototype | Preclinical studies | Phase 1 trials | Phase 2 trials | Available/ Partnered | |
|---|---|---|---|---|---|---|
Group A Streptococcus (peptide conjugate) | x | x | x | x | A | |
Group A Streptococcus (liposomal formulation) | x | x | x | P | ||
Malaria (attenuated whole parasite blood stage) | x | x | x | x | A | |
Gonorrhoea (5 antigens) | x | x | x | A | ||
Chikungunya virus (attenuated virus) | x | x | n | A | ||
Zika virus (attenuated virus) | x | x | x | P | ||
HIV (virus-like particle) | x | x | A | |||
Middle ear infection | x | x | A | |||
Babesiosis | x | x | A | |||
Meningitis | x | A |
Drugs
Target Discovery | Hits / | Preclinical studies | Phase 1 trials | Phase 2 trials | Available/ Partnered | |
|---|---|---|---|---|---|---|
Ross River virus (small molecule) | x | x | x | x | P | |
Croup/Human Parainfluenza Virus 1 & 3 (small molecule) | x | x | A | |||
Influenza (small molecule) | x | x | A | |||
Hand, foot and mouth disease (small molecule) | x | x | A | |||
Sepsis (small molecule) | x | x | x | x | x | P |
Anticancer agent (peptide inhibitor) | x | x | A | |||
Antibacterial agent (peptide inhibitor) | x | x | A | |||
Streptococcal Toxic Shock Syndrome (mAbs therapeutic) | x | x | x | A | ||
Gonorrhoea (small molecule) | x | x | x | x | A | |
Wound healing agents (small molecule) | x | x | A | |||
Triple-negative breast cancer | x | A | ||||
Head and neck cancer | x | A | ||||
Ovarian cancer | x | A | ||||
Leukaemia (small molecule) | x | x | A | |||
Melanoma | x | A | ||||
Prostate cancer | x | A | ||||
Stomach cancer | x | A | ||||
Respiratory Syncytial Virus (RSV) | A | |||||
Food-borne allergens | x | x | A | |||
HIV | x | A | ||||
Tuberculosis (small molecule) | x | x | A | |||
Gastroenteritis (antibiotic) | x | x | A |
Diagnostics, technology platforms and other
Type | Stage | Available/ Partnered | |
|---|---|---|---|
Cancer diagnostic (biomarker) | Diagnostic | Prototype | A |
Glycan Array (platform product) | Service | On market | N/A |
Prebiotics and nutritional products | Technology | Discovery | A |
Sulfation method | Method | On market | A |
Prebiotics and nutritional products | Service | On market | N/A |